Status | Study |
RECRUITING |
Study Name: Mechanisms of Anabolic Osteoporosis Therapy Condition: Osteoporosis, Postmenopausal Date: 2023-01-09 Interventions: early (3-6 weeks) versus late (6-8 months) biopsy |
Not yet recruiting |
Study Name: The Deferasirox-calcium-vitamin D3 Therapy for Postmenopausal Osteoporosis (PMOP) Condition: Postmenopausal Osteoporosis Date: 2016-07-19 Interventions: Drug: Deferasirox and calcium-vitamin D3 |
Completed |
Study Name: A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis Condition: Postmenopausal Osteoporosis Date: 2015-11-04 Interventions: Drug: Alendronate Participants |
Completed |
Study Name: A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis Condition: Post Menopausal Osteoporosis Date: 2015-11-04 Interventions: Drug: Ibandronate Participants will receive oral ibandronate, 150 mg once weekly, for approximately 6 mo |
Completed |
Study Name: Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in Pakistan Condition: Postmenopausal Osteoporosis Date: 2015-04-16 |
Completed |
Study Name: Study on the microRNA Expression Level in Postmenopausal Osteoporosis Condition: Postmenopausal Osteoporosis Date: 2014-03-14 Interventions: Other: osteoporosis |
Completed |
Study Name: Study With AMG 785 to Treat Japanese Women With Postmenopausal Osteoporosis Condition: Postmenopausal Osteoporosis (PMO) Date: 2013-11-19 Interventions: Drug: AMG 785 AMG 785 subcutan |
Completed |
Study Name: Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Denosumab (Prolia®) in Routine Clinical Practice Condition: Osteoporosis, Postmenopausal Date: 2012-07-26 Interventions: Biological: Denosumab This is an non-interventional study, therefore denosumab is administered as part o |
Completed |
Study Name: Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis Condition: Postmenopausal Osteoporosis Date: 2011-07-29 Interventions: Other: Observation In this study we will examine the changes in bone density by DXA and QUS and bone tur |
Completed |
Study Name: Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan Condition: Osteoporosis, Postmenopausal Date: 2011-07-19 Interventions: Drug: E2 transdermal (Julina, BAY86-5435) Patients in daily life treatment receiving Julina for postmeno |